Drug: ABREVA Injury: Application site erythema Quarter: 2016Q3
Total Records: 6 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
125466591 | ABREVA | Application site erythema | GLAXOSMITHKLINE | 38.00 YR | F | 0 | 20160711 | US |
126147382 | ABREVA | Application site erythema | GLAXOSMITHKLINE | 88.00 YR | F | 0 | 20160902 | US |
127365021 | ABREVA | Application site erythema | GLAXOSMITHKLINE | 0.00 | M | 0 | 20160912 | US |
127366322 | ABREVA | Application site erythema | GLAXOSMITHKLINE | 0.00 | 0 | 20160919 | US | |
127662861 | ABREVA | Application site erythema | GLAXOSMITHKLINE | 66.00 YR | F | 0 | 20160921 | US |
127977871 | ABREVA | Application site erythema | GLAXOSMITHKLINE | 0.00 | 0 | 20160930 | US |
Total Records: 6 Number of Pages: 1